CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later) 		 
     
 
 
 
Beijing SL Pharmaceutical Co., Ltd. Company Snapshot
Business Description:
Beijing SL Pharmaceutical Co., Ltd. operates in the Biological products exc. diagnostic sector. Beijing SL Pharmaceutical Co., Ltd. is principally engaged in the development, production and sale of gene engineering drugs. The Company provides four categories of products: biological products, including rhG-CSF injections, interleukin-2 injections, rhIL-11 injections and rh-bFGF; biochemicals, such as cytidine disodium triphosphate for injection, calcium folinate for injection, salmon calcitonin injection, coenzyme complex for injection, netilmicin sulfate injection, matrine injection and ciclosporin injection; tablets and capsules, including desloratadine orally-disintegrating tablets, zaleplon capsules, naftopidil tablets, tropisetron hydrochloride capsules, telmisartan tablets, metformin hydrochloride and glyburide tablets and stavudine capsules, and health-care food, including Hongxin Capsule. It distributes its products in domestic and overseas markets. In our complete report available for purchase the company is compared to: Tianjin Ringpu Bio-technology Co Ltd, Walvax Biotechnology Company Limited and Shanghai Jiaoda Onlly Co., Ltd..
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Beijing SL Pharmaceutical Co., Ltd.
  Stock Performance Chart for Beijing SL Pharmaceutical Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (2/3/2012): 27.20
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks -4.3%  
4 Weeks -22.9%   52 Weeks -23.8%  
 
Beijing SL Pharmaceutical Co., Ltd. Key Data:
  Ticker: 002038 Country: CHINA
  Exchanges: SZN Major Industry: Drugs, Cosmetics & Health Care
    Sub Industry: Ethical Drug Manufacturers
  2010 Sales 457,842,000
(Year Ending Jan 2011).		 Employees: 376
  Currency: Chinese Renmimbi Market Cap: 10,355,040,000
  Fiscal Yr Ends: December Shares Outstanding: 380,700,000
  Share Type: A Shares Closely Held Shares: N/A
 
 
Featured Products and Services
  
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.